Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other financing activities (2016)

Iradimed (IRMD) has disclosed Other financing activities for 3 consecutive years, with $53122.0 as the latest value for Q4 2016.

  • On a quarterly basis, Other financing activities fell 93.75% to $53122.0 in Q4 2016 year-over-year; TTM through Dec 2016 was $603553.0, a 65.08% decrease, with the full-year FY2024 number at -$131075.0, down 2138.49% from a year prior.
  • Other financing activities was $53122.0 for Q4 2016 at Iradimed, down from $284337.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.8 million in Q3 2014 to a low of $49807.0 in Q2 2015.
  • A 3-year average of $463696.8 and a median of $209515.0 in 2016 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 320.65% in 2016; the steepest drop was 93.75% in 2016.
  • Iradimed's Other financing activities stood at $1.8 million in 2014, then crashed by 53.81% to $850449.0 in 2015, then tumbled by 93.75% to $53122.0 in 2016.
  • Per Business Quant, the three most recent readings for IRMD's Other financing activities are $53122.0 (Q4 2016), $284337.0 (Q3 2016), and $209515.0 (Q2 2016).